Paul Riley: Is Thrombin Generation Assay Ready for Prime Time?
Paul Riley, Scientific Marketing Manager at Diagnostica Stago, shared on LinkedIn about his recent article, adding:
”Happy to share a new review article on thrombin generation testing I wrote and recently accepted by Clinics in Laboratory Medicine for a special edition.
The article describes a assay I am very passionate about which has the potential to give clinicians better information about patients’ global risk of bleeding or thrombosis.
The assay is not FDA cleared but available for research in the US and Canada.
It is being used in clinical settings internationally, though in limited volume.
Hopefully usage will increase over time especially if there’s a successful FDA submission at some point.
Thank you to the editors for inviting me to contribute.”
Title: Thrombin Generation Assay: Ready for Prime Time
Authors: Paul Riley
Read the Full Article on Clinics in Laboratory Medicine
Stay updated on all scientific advances with Hemostasis Today.
-
Mar 12, 2026, 20:28Rob Maloney: Building Visibility for Bleeding Disorders in Rural Georgia
-
Mar 12, 2026, 20:19Akshat Jain: Validating Oral Pain Medication Use as a Global Marker in Sickle Cell Disease
-
Mar 12, 2026, 20:13Michael Makris: Early Clinical Results of AAV8-BDD FVIII Gene Therapy in Hemophilia A
-
Mar 12, 2026, 20:02Wolfgang Miesbach: From Heparin to Vaccines – The Expanding Biology of Anti-PF4 Immunothrombosis
-
Mar 12, 2026, 19:56Christophe Dubois: Celebrating Nicolas Gendron’s HDR Defense and Future in Hemostasis
-
Mar 12, 2026, 17:06Caitlin Raymond: Managing Crigler–Najjar Syndrome Type 1 Crisis Without a Standard TPE Protocol
-
Mar 12, 2026, 17:03Jan Sloves: Insights on Comprehensive Venous Duplex Imaging at VEITH Symposium 2025
-
Mar 12, 2026, 16:36Giordano Botta: From the ‘Power of Zero’ to a Precise Understanding of Cardiovascular Risk
-
Mar 12, 2026, 16:31Katie Baca-Motes: Incorporating Menstrual Cycle and Hormonal Rhythms Into Clinical Research